There is a cannabis revolution taking place all over the global and we are seeing cannabis reform taking place all around the world.
During the last two years, Brazil, Mexico, Paraguay, Puerto Rico, Canada, Uruguay, Jamaica, Portugal, and the Netherlands have taken steps to legalize or decriminalize cannabis.
Mexico’ Passes Legislation to Legalize Medical Cannabis
On Friday, this trend continued after Mexico’s lower house passed legislation approving the use of medical cannabis. The Health Department will be responsible for creating public policies to regulate the use of medical cannabis and its derivatives.
The legislation allows for the cultivation of cannabis plants for medical and scientific purposes and makes it legal to buy, sell, import and export industrial products with less than 1% THC.
Legislation Sent to Mexico’s President
Mexico has been one of the states to make significant changes to its cannabis laws during the last year. The passing of the legislation on Friday is a major step for the country as it will now go to Mexico’s President Enrique Pena Nieto to be signed into law.
In 2016, the Mexican government decriminalized the possession of small amounts of cannabis and issued permits to cultivate and possess medical cannabis for personal use Last year, the country also started granting permits allowing patients to import medical cannabis products.
A Growing Trend
Over the last month, we have seen a significant increase in the number of cannabis reform initiatives and it is only a matter of time until cannabis is made completely legal.
Although there are concerns regarding what United States Attorney General Jeff Sessions will do to the legal cannabis industry in the United States, the global cannabis industry is not waiting on Sessions to decided and the time to act is now!
Like or share if you support the legalization of medical cannabis!
Important Investor Disclosures
Disclosure. Compensated Affiliate. This report was authored by and is property of Technical420. All information and data relied upon in drafting this report is publicly available. The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report. Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice. Any projections or other information generated by Technical420 regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results. None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment. This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation. The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals. It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction. Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks. The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission. Please contact a Financial Advisor for professional advice regarding any and all securities investments. This report is intended for informational purposes only. Technical420’s officers, directors, employees, affiliates, or subsidiaries may have positions in securities covered by Technical420. Technical420 may receive compensation from the company and/or has a position in the securities mentioned in this report
Source: Technical 420